Sage Journals: Discover world-class research

Abstract

Objectives

We investigated the expression and clinical significance of activin receptor–like kinase 1 (ACVRL1) in patients with head and neck squamous cell carcinoma (HNSCC).

Study Design

Case series with chart review.

Setting

Academic Institute of Otolaryngology, Kaohsiung, Taiwan.

Subjects and Methods

Patients diagnosed with HNSCC (n = 169) underwent surgical resection followed by radiotherapy and/or chemotherapy for aggressive tumors between November 2000 and March 2004. ACVRL1 expression was assessed using quantitative reverse transcription polymerase chain reaction (qRT-PCR) and immunohistochemistry approaches.

Results

High levels of ACVRL1 expression were significantly correlated with advanced T classification (P < .001), positive N classification (P = .002), advanced TNM stage (P < .001), lymphovascular invasion (P < .001), and extracapsular spread of lymph node metastasis (P = .021). A poor 5-year overall survival rate was correlated with high ACVRL1 expression (P = .0048), advanced T classification (P = .0075), positive N classification (P = .0024), advanced TNM stage (P = .0077), and extracapsular spread of lymph node (P = .0002), but a multivariate analysis using the Cox regression model revealed that the only independent prognostic factors for survival were ACVRL1 expression (P = .043; odds ratio [OR], 1.635; 95% confidence interval [CI], 1.017-2.629) and extracapsular spread of lymph node metastasis (P = .003; OR, 2.052; 95% CI, 1.270-3.315).

Conclusion

A high level of ACVRL1 expression in tumor tissue is significantly correlated with advanced T classification, positive N classification, advanced TNM stage, and poorer prognosis.

Keywords

activin receptor–like kinase 1 head and neck squamous cell carcinoma neck metastasis extracapsular spread of lymph node lymph node metastasis

Get full access to this article

View all access options for this article.

References

Greenlee

Hill-Harmon

Murray

Thun

. Cancer statistics, 2001. CA Cancer J Clin. 2001;51:15-36.

Cancer Registry Annual Report in Taiwan Area. Taipei, ROC: Department of Health EY; 2006.

Folkman

. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990;82:4-6.

Folkman

. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med. 1995;333:1757-1763.

Weidner

. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 1995;147:9-19.

Polverini

Leibovich

. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest. 1984;51:635-642.

Seki

Goss

. Activin receptor–like kinase 1 modulates transforming growth factor–beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A. 2000;97:2626-2631.

Hu-Lowe

Chen

Zhang

. Targeting activin receptor–like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies. Cancer Res. 2011;71:1362-1373.

Abdalla

Letarte

. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet. 2006;43:97-110.

10.

Al-Swiahb

Chen

Chuang

Fang

Tasi

Chien

. Clinical, pathological and molecular determinants in squamous cell carcinoma of the oral cavity. Future Oncol. 2010;6:837-850.

11.

Chen

Chien

Huang

. Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity. Oncogene. 2009;28:2723-2737.

12.

Chuang

Huang

Chien

Chen

Huang

. High expression of CD105 as a prognostic predictor of early tongue cancer. Laryngoscope. 2006;116:1175-1179.

13.

Chien

Hwang

. Clinicopathologic significance of CD105 expression in squamous cell carcinoma of the hypopharynx. Head Neck. 2006;28:441-446.

14.

Marioni

Staffieri

Manzato

. A higher CD105-assessed microvessel density and worse prognosis in elderly patients with laryngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2011;137:175-180.

15.

Martone

Rosso

Albera

. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome. Oral Oncol. 2005;41:147-155.

16.

Chen

Chien

. Overexpression of beta2-microglobulin is associated with poor survival in patients with oral cavity squamous cell carcinoma and contributes to oral cancer cell migration and invasion. Br J Cancer. 2008;99:1453-1461.

17.

Wiltshire

Batalov

. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A. 2004;101:6062-6067.

18.

Garrido-Martin

Blanco

Fernandez

. Characterization of the human activin-A receptor type II–like kinase 1 (ACVRL1) promoter and its regulation by Sp1. BMC Mol Biol. 2010;11:51.

19.

Srinivasan

Hanes

Dickens

. A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. Hum Mol Genet. 2003;12:473-482.

20.

Cunha

Pietras

. ALK1 as an emerging target for antiangiogenic therapy of cancer. Blood. 2011;117:6999-7006.

21.

Goumans

Valdimarsdottir

Itoh

Rosendahl

Sideras

ten Dijke

. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J. 2002;21:1743-1753.

22.

Shi

Massague

. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113:685-700.

23.

Mallet

Vittet

Feige

Bailly

. TGFbeta1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5. Stem Cells. 2006;24:2420-2427.

24.

Freudlsperger

Bian

Contag Wise

. TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers [published online May 28, 2012]. Oncogene. doi:10.1038/onc.2012.171.

25.

Jonson

Albrechtsson

Axelson

. Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas. Int J Oncol. 2001;19:71-81.

26.

Lamouille

Mallet

Feige

. Activin receptor–like kinase 1 is implicated in the maturation phase of angiogenesis. Blood. 2002;100:4495-4501.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

10.43 MB

The Expression of Activin Receptor–Like Kinase 1 among Patients with Head and Neck Cancer

Abstract

Objectives

Study Design

Setting

Subjects and Methods

Results

Conclusion

Keywords

Get full access to this article

References

Supplementary Material